Dr. Marquez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2589 Samaritan Drive
San Jose, CA 95124Phone+1 408-426-4900
Summary
- Dr. Carol Marquez is a radiation oncologist in San Jose, CA and is affiliated with multiple hospitals in the area, including Lucile Packard Children's Hospital Stanford, Emanuel Medical Center, Stanford Health Care, and El Camino Hospital. She received her medical degree from University of California San Francisco School of Medicine and has been in practice 30 years. She specializes in benign diseases, breast cancer, and central nervous system cancer and is experienced in breast cancer, lung cancer, paget's disease of the breast, epidermoid cancer of the anus, and bronchial cancer.
Education & Training
- University of California (San Francisco)Residency, Radiation Oncology, 1987 - 1991
- University of California San Francisco School of MedicineClass of 1987
Certifications & Licensure
- OR State Medical License 1993 - Present
- CA State Medical License 2015 - 2025
- WA State Medical License 1996 - 2017
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Relaxation and Visualization Therapy for Breast Cancer Patients Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 272 citationsYttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphomaSusan J. Knox, Michael L. Goris, Kirk Trisler, Robert S. Negrin, Thomas E. Davis
Clinical Cancer Research. 1996-03-01 - 25 citationsONS Guidelines™ for Cancer Treatment-Related Radiodermatitis.Tracy K. Gosselin, Pamela K. Ginex, Chelsea Backler, Susan D. Bruce, Andrea Hutton
Oncology Nursing Forum. 2020-11-01 - 100 citationsTreatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.Nimisha Deb, Michael L. Goris, Kirk Trisler, Sherry Fowler, Jeannette Saal
Clinical Cancer Research. 1996-08-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: